维普中文期刊产品整合服务
31篇 您的检索式:作者名="Ponseti JM"
    题名 作者 年代 出处 被引量
1Tacrolimus for myasthenia gravis: a clinical study of 212 patients显示文摘Ponseti JM Gamez J Azem J 2008Ann N Y Acad Sci2008,1132,:1
2Pancreatic endocrine tu-mors or apudomas显示文摘Varas M Gornals J Ponseti JM AlastruèA Durán C Llevaria C Ballesta C Díez Caballero A Artigas V 2011Rev Esp Enferm Dig2011,103,:1
3Long-term results of tacrolimus in cyclosporine-and prednisone-dependent myasthenia gravis 显示文摘Ponseti JM Azem J Fort JM 2005Neurology2005,64,:1
4Benefits of FKS06 ( tacrolimus) for residual cyclosporin and prednisone resistant myasthenia gravis:one year follow up of an open label study显示文摘Ponseti JM Azem J Fort JM 2005Clin Neurol Neurosurg2005,107,3:1
5Benefits of FK506 (tacrolimus) for residual,cyclosporin-and prednisone-resistant myasthenia gravis:one-year follow-up of an open-label study显示文摘Ponseti JM Azem J Fort JM 2005Clin Neurol Neurosurg2005,107,:1
6Tacrolimus for myasthenia gravis:a clinical study of 212 patients显示文摘Ponseti JM Gamez J Azem J 2008Ann N Y Aead Sci2008,1132,:1
7Benefits of FK506 (tacrolimus) for residual,cyclosporineand prednisone resistant myasthenia gravis:one year follow-up of an open-label study显示文摘Ponseti JM Azem J Fort JM 2005Clin Neurol Neurosurg2005,107,:1
8Long-term results of tacrolimus in cyclosporineand prednisone-dependent myasthenia gravis显示文摘Ponseti JM Azem J Fort JM 2005Neurology2005,64,:1
9Pancreatic endocrine tumors or apudomas 显示文摘VARAS M GORNALS J PONSETI JM 2011Rev Esp Enferm Dig2011,103,4:1
10Benefits of FK506 (tacrolimus) for residual, cyclosporin - and prednisone - resistant myasthenia gravis : one - year follow - up of an open - label study 显示文摘Ponseti JM Azem J Fort JM 2005Clin Neurol Neurosurg2005,107,3:1
11Post-thymectomy combined treatment of prednisone andtacrolimus versus prednisone alone for consolidationof complete stable remission in patients with myas-thenia gravis: a non-randomized, non-controlledstudy 显示文摘Ponseti JM Gamez J Azem J 2007Curr Med Res Opin2007,23,:1
12Tacrolimusfor Myasthenia Gravis: A Clinical Study of 212Patients显示文摘Ponseti JM Gamez J Azem J 2008Ann N Y Acad sci2008,1132,:1
13Benefits ofKF506 (tacrolimus) for residual, cyclosporin- andprednisone-resistant myasthenia gravis: one-yearfollow-up of an open-label study 显示文摘Ponseti JM Azem J Fort JM 2005Clin NeurolNeurosurg2005,107,:1
14Long-termresults of tacrolimus in cyclosporine- andprednisone-dependent myasthenia gravis 显示文摘Ponseti JM Azem J Fort JM 2005Neurology2005,64,:1
15Benefits of FK506 (tacrolimus) for residual,cyclosporin-and prednisone-resistant myasthenia gravis:one-year follow-up of an open-label study显示文摘Ponseti JM Azem J Fort JM 2005Clin Neurol Neurosurg2005,107,3:1
16Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis显示文摘Ponseti JM Gamez J Vilallonga R 2008Eur J Cardiothorac Surg2008,34,:1
17Experience with Starting Tacrolimus P0stoperatively after Transsternal Extended Thymectomy in Patients with Myasthenia Gravis显示文摘PONSETI JM AZEM J FORT JM 2006Curr Med Res Opin(S0300-7995)2006,22,5:1
18Benefits of FK506 (tacrolimus) for residual,cyclosporin-and prednisone-resistant myasthenia gravis:one-yearfollow-up of an open-label study显示文摘Ponseti JM Azem J Fort JM 2005Clin Neurol Neurosurg2005,107,3:1
19Tacrolimus for myasthenia gravis:a clinical study of 212 patients显示文摘Ponseti JM Gamez J Azem J 2008Ann N Y Acad Sci2008,1132,:1
20Experience with Starting Taerolimus Post Operati Vely after Transsternal Extended Thymectomy in Patients with Myasthenia Gravis显示文摘Ponseti JM Azem J Fort JM 2006Curr Med Res Opin(S0300-7995)2006,22,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费